POS0590 SAFETY AND EFFICACY OF BIOLOGICS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS IN A REAL WORLD STUDY: USE OF INTRAVENOUS GOLIMUMAB AND INFLIXIMAB IN ADULTS WITH RHEUMATOID ARTHRITIS ≥65 YEARS OF AGE
Joy Schechtman, Aaron Broadwell, Shelly Kafka, Simon Black, S. Xu, Wayne Langholff, Sergio Schwartzman
Topics & Concepts
MedicineGolimumabDiscontinuationRheumatoid arthritisInfliximabInternal medicineClinical endpointPhysical therapySurgeryClinical trialEtanerceptDiseaseChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentImmunodeficiency and Autoimmune Disorders